Breast Cancer Clinical Trial
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
Summary
This is an open-label Phase 1b dose-escalation study to assess the safety, tolerability, and PK of vantictumab when combined with paclitaxel.
Full Description
Once the maximum tolerated dose (MTD) or maximum administered dose (MAD) has been determined, up to 10 patients may be enrolled in the cohort-expansion phase to better characterize the safety, tolerability and PK of vantictumab combined with paclitaxel. Up to approximately 34 patients may be enrolled into the study.
Eligibility Criteria
Inclusion Criteria:
Signed Informed Consent Form
Age ≥18 years
Histologically documented adenocarcinoma of the breast with locally recurrent or metastatic disease
o Patients with breast cancer overexpressing HER2 are not eligible.
Availability of tumor tissue, either archival FFPE or obtained at study entry through fresh biopsy
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
All acute treatment-related toxicity from prior therapy must have resolved to Grade ≤ 1 prior to study entry
Adequate hematologic and end-organ function
Evaluable or measurable disease per RECIST v1.1
For women of childbearing potential, agreement to use two effective forms of contraception
Exclusion Criteria:
Known significant dose delays during prior treatment with a taxane due to drug-related toxicities
Prior treatment with more than two regimens of systemic cytotoxic chemotherapy for locally recurrent or metastatic disease
Treatment with any anti-cancer therapy within 3 weeks prior to initiation of study treatment
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 4 Locations for this study
Los Angeles California, 90048, United States
Aurora Colorado, 80045, United States
Dallas Texas, 75246, United States
Tyler Texas, 75702, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.